Back
Esperion Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
ESPR
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
26
ESPR
Esperion Therapeutics
Last Price:
1.72
Seasonality Move:
4.15%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly optionsEsperion Therapeutics Price Quote
$1.72
-0.02 (-0.86%)
(Updated: September 20, 2024 at 9:35 AM ET)
Esperion Therapeutics Key Stats
Sell
26
Esperion Therapeutics (ESPR)
is a Sell
Day range:
$1.73 - $1.85
52-week range:
$0.70 - $3.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.94
P/B ratio:
0%
Volume:
3.1M
Avg. volume:
3.7M
1-year change:
39.92%
Market cap:
$340.4M
Revenue:
$116.3M
EPS:
$-0.86
How Much Does Esperion Therapeutics Make?
-
How Much Are Esperion Therapeutics's Sales Annually?
ESPR Revenues are $116.3M -
How Much Profit Does Esperion Therapeutics's Make A Year?
ESPR net income is -$209.2M
Is Esperion Therapeutics Growing As A Company?
-
What Is Esperion Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.86% -
What Is Esperion Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Esperion Therapeutics Stock Price Performance
-
Did Esperion Therapeutics Stock Go Up Last Month?
Esperion Therapeutics share price went down by -8.68% last month -
Did ESPR's Share Price Rise Over The Last Year?
ESPR share price rose by 39.92% over the past 1 year
What Is Esperion Therapeutics 52-Week High & Low?
-
What Is Esperion Therapeutics’s 52-Week High Share Price?
Esperion Therapeutics has traded as high as $3.40 over the past 52 weeks -
What Is Esperion Therapeutics’s 52-Week Low Share Price?
Esperion Therapeutics has traded as low as $0.70 over the past 52 weeks
Esperion Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Esperion Therapeutics?
-
How Much Debt Does Esperion Therapeutics Have?
Total long term debt quarterly is $262.5M -
How Much Cash Does Esperion Therapeutics Have?
Cash and short term investments quarterly total is $189.3M -
What Is Esperion Therapeutics’s Book Value Per Share?
Book value per share is -1.77
Is Esperion Therapeutics Cash Flow Positive?
-
What Is ESPR Cash Flow From Operations?
Cash flow from operations (TTM) is -$9.8M -
What Is Esperion Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $60.7M -
What Is Esperion Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$150K
Esperion Therapeutics Return On Invested Capital
Data Unavailable
Esperion Therapeutics Earnings Date & Stock Price
-
What Is Esperion Therapeutics's Stock Price Today?
A single share of ESPR can be purchased today for 1.74 -
What Is Esperion Therapeutics’s Stock Symbol?
Esperion Therapeutics trades on the nasdaq under the ticker symbol: ESPR -
When Is Esperion Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Esperion Therapeutics is scheduled on November 7, 2024 -
When Is ESPR's next ex-dividend date?
Esperion Therapeutics's next ex-dividend date is September 20, 2024 -
How To Buy Esperion Therapeutics Stock?
You can buy Esperion Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Esperion Therapeutics Competitors
-
Who Are Esperion Therapeutics's Competitors?
Below is a list of companies who compete with Esperion Therapeutics or are related in some way:
Esperion Therapeutics Dividend Yield
-
What Is ESPR Dividend Yield?
Esperion Therapeutics’s dividend yield currently is 0% -
What Is Esperion Therapeutics’s Payout Ratio?
Esperion Therapeutics’s payout ratio is 0% -
When Did Esperion Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Esperion Therapeutics’s Dividend Per Share?
Esperion Therapeutics pays a dividend of $0.00 per share
Esperion Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 72.55% |
Revenue: | 186.33% | 55.44% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 7.59 |
Upside from Last Price: | 337.56% |